Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Breast (Edinburgh, Scotland)|June 27, 2026
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trialChiara Molinelli, Virginia Delucchi, Eva Blondeaux, et al.Breast (Edinburgh, Scotland)|October 9, 2025
Fertility and ovarian function preservation in young women with breast cancer: A joint analysis of the Joven & Fuerte and PREFER prospective studiesFernanda Mesa-Chavez, Maria Grazia Razeti, Eva Blondeaux, et al.Breast (Edinburgh, Scotland)|February 14, 2026
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysisLuca Arecco, Pedro M Cacilhas, Camila Bobato Lara Gismondi, et al.European Journal of Clinical Investigation|February 13, 2025
Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysisMarta Perachino, Eva Blondeaux, Chiara Molinelli, et al.Breast (Edinburgh, Scotland)|May 7, 2025
Physicians' knowledge, practice, and attitudes on fertility and pregnancy-related issues in young women with advanced breast cancer: results of the ABC6 and ABC7 surveySimone Nardin, Luca Arecco, Virginia Delucchi, et al.Breast (Edinburgh, Scotland)|July 23, 2024
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER studyLuca Arecco, Maria Maddalena Latocca, Eva Blondeaux, et al.Eclinicalmedicine|April 30, 2024
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trialsEva Blondeaux, Wanling Xie, Luca Carmisciano, et al.European Journal of Cancer (Oxford, England : 1990)|February 6, 2026
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studiesSimone Nardin, Marco Bruzzone, Luca Arecco, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021
Pregnancy After Breast Cancer: A Systematic Review and Meta-AnalysisMatteo Lambertini, Eva Blondeaux, Marco Bruzzone, et al.The Lancet. Oncology|November 12, 2022
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trialLucia Del Mastro, Francesca Poggio, Eva Blondeaux, et al.Pageof 6